Spain Inflammatory Bowel Disease Treatment Market Size & Outlook
Spain inflammatory bowel disease treatment market, 2018-2030 (US$M)
Related Markets
Spain inflammatory bowel disease treatment market highlights
- The Spain inflammatory bowel disease treatment market generated a revenue of USD 351.0 million in 2023 and is expected to reach USD 495.2 million by 2030.
- The Spain market is expected to grow at a CAGR of 5% from 2024 to 2030.
- In terms of segment, crohn's disease was the largest revenue generating type in 2023.
- Ulcerative Colitis is the most lucrative type segment registering the fastest growth during the forecast period.
Inflammatory bowel disease treatment market data book summary
| Market revenue in 2023 | USD 351.0 million |
| Market revenue in 2030 | USD 495.2 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Crohn's disease |
| Fastest growing segment | Ulcerative Colitis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Crohn's Disease, Ulcerative Colitis |
| Key market players worldwide | AbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare |
Other key industry trends
- In terms of revenue, Spain accounted for 1.7% of the global inflammatory bowel disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany inflammatory bowel disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 65.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inflammatory Bowel Disease Treatment Market Scope
Inflammatory Bowel Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain inflammatory bowel disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.
Crohn's disease was the largest segment with a revenue share of 60.11% in 2023. Horizon Databook has segmented the Spain inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is one of the most lucrative markets in Europe. According to an article published by UCB S.A., in 2019, around 900,000 people suffered from Crohn’s disease in the top seven markets, which included the U.S., Spain, the UK, Italy, Japan, Germany, and France. In addition, presence of key players, such as Pfizer, AbbVie, Gilead Sciences, UCB, and Shire, is expected to drive the country’s market.
In addition, supportive regulatory framework for pharmaceuticals is further accelerating the market. For instance, in September 2019, Janssen Pharmaceuticals of J&J announced that the European Commission approved the expanded use for the management of adults with severe ulcerative colitis.
Moreover, various factors like high-quality treatment providers, promised reimbursement programs, public-private partnerships, and high expenditure on healthcare are driving the market.
Reasons to subscribe to Spain inflammatory bowel disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain inflammatory bowel disease treatment market databook
-
Our clientele includes a mix of inflammatory bowel disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain inflammatory bowel disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Spain inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain inflammatory bowel disease treatment market size, by type, 2018-2030 (US$M)
Spain Inflammatory Bowel Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
